Abstract:Abstract Introduction Insomnia is diagnosed based on subjective difficulty falling asleep, staying asleep, and early morning awakenings. Evidence of objective EEG abnormalities is mixed, in part due to small sample sizes and variable definitions of insomnia. This study aimed to explore these issues by comparing the insomnia case group and the control group on sleep physiology objectively measured depending on separate qualitative and quantitative self-reported insomnia symptoms. Methods Analyses are based on questionnaires and PSG data from the Sleep Apnea Global Interdisciplinary Consortium (SAGIC). Two distinct insomnia case groups were defined. A qualitative insomnia case was defined as self-reported difficulty falling or staying asleep at least 3 nights/week for more than 3 months and moderate or greater impairment in daytime function due to poor sleep (n=350, 58% female; 48.47±14.38 years). The quantitative case definition required average self-reported sleep latency or wakefulness after sleep onset >30 minutes combined with the frequency and impairment criteria. (n=196, 62% female; 48.77±13.74 years). We also defined control groups without insomnia. Participants were excluded if they had sleep apnea (apnea-hypopnea index [AHI] > 5 events/hour) or were shift workers. Multivariate analysis of variance (MANOVA) models, adjusted for age and sex, were separately conducted to compare the insomnia and control groups. The focus was on traditional sleep architecture variables, EEG power within specific frequency bands, and odds ratio product (ORP, representing sleep depth) metrics. Results The MANOVA analysis indicated significant group differences, with post-hoc tests identifying key variables responsible for these distinctions. In qualitative criteria, sleep onset latency, sigma, beta1, and beta2 in EEG1 and EEG2, along with REM and NREM ORP, were significant contributors to the observed differences. In quantitative criteria, besides the same result in qualitative criteria, REM stage and alpha in EEG1 and EEG2 played significant roles. Effect sizes were consistent across both qualitative and quantitative criteria. Conclusion While the analyses depending on qualitative and quantitative criteria did not have different effect sizes, some variables contributed to the group differences. As such, the results of this study support the idea that qualitative and quantitative criteria measure the same dimensions for physiological differences related to insomnia. Support (if any)

Comparative Polysomnography Parameters Between Narcolepsy Type 1/type 2 and Idiopathic Hypersomnia: A Systematic Review and Meta-Analysis.

Polysomnographic Nighttime Features of Narcolepsy: A Systematic Review and Meta-Analysis

Differential characteristics of repeated polysomnography and multiple sleep latency test parameters in narcolepsy type 1 and type 2 patients: a longitudinal retrospective study

The nature and magnitude of cognitive impairment in narcolepsy type 1, narcolepsy type 2, and idiopathic hypersomnia: a meta-analysis

0670 Patterns of Nocturnal Sleep Disruption: Differentiating IH from NT2 Using Cluster Analysis

0599 Sleep Stage Transition Patterns Among Youth with CNS Disorders of Hypersomnolence

Regional brain metabolism differs between narcolepsy type 1 and idiopathic hypersomnia

Altered functional connectivity and spatiotemporal dynamics in individuals with sleep disorders

Psychiatric comorbidity in Danish patients with narcolepsy type 1, narcolepsy type 2, and idiopathic hypersomnia: a case-control study

Probabilistic Sleep Staging in MSLTs across Hypersomnia Disorders

Lipocalin-type prostaglandin D synthase levels increase in patients with narcolepsy and idiopathic hypersomnia

0428 Comparative Analysis of Sleep Physiology Using Qualitative and Quantitative Criteria for Insomnia Symptoms

Sleep in Amyotrophic Lateral Sclerosis: A Systematic Review and Meta-Analysis of Polysomnographic Findings

Alterations in the DTI-ALPS index and choroid plexus volume are associated with clinical symptoms in participants with narcolepsy type 1

Distinguishing between children referred for assessment of excessive daytime sleepiness using polysomnographic measures.

Sleep in Huntington's Disease: a Systematic Review and Meta-Analysis of Polysomongraphic Findings.

Compromised Dynamic Cerebral Autoregulation in Patients With Central Disorders of Hypersomnolence

Spectral Analysis of Polysomnography in Narcolepsy

Altered Sleep Stage Transitions of REM Sleep: A Novel and Stable Biomarker of Narcolepsy

1176 Extended Polysomnography Confirms Idiopathic Hypersomnia Diagnoses: A Case Series

Narcolepsy Severity Scale-2 and Idiopathic Hypersomnia Severity Scale to better quantify symptoms severity and consequences in Narcolepsy type 2